Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Santé Cannabis has provided assessment and support to over 20,000 patients since 2014. It leads clinical research on medical cannabis efficacy and safety—including a major ongoing real-world evidence study of new product formats—and launched a patient-centered psychedelic-assisted therapy program in 2024. The company holds four Health Canada Cannabis Research Licences for conducting both interventional clinical trials and observational studies. It partners with leading industry players to advance access to legal treatments while supporting healthcare professional education.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Santé Cannabis.